British Patient Capital
Venture capital firm based in Sheffield, UK
British Patient Capital Investments
British Patient Capital has invested in these startups.
Tenpoint Therapeutics
Cambridge-based biotech firm, Tenpoint Therapeutics, secures $70M in Series A funding to advance regenerative medicine platform and restore vision for individuals with degenerative ocular diseases. Read more
Curve Therapeutics
Curve Therapeutics, backed by $40.5M in funding from industry giants like Pfizer Ventures, is revolutionizing drug discovery to tackle complex diseases and push the boundaries of biotechnology. Read more
Phagenesis
Phagenesis secures $42M in funding to revolutionize treatment for swallowing dysfunction, poised to expand globally with groundbreaking neurostimulation system. Read more
Wagestream
Wagestream secures £300M funding from Citi, driving employee financial wellbeing and transforming workplace health across the UK! Read more
Epsilogen
Epsilogen is revolutionizing cancer treatment with groundbreaking IgE antibodies and a £12.5 million boost in funding, propelling them towards a potential game-changer for patients battling solid tumors! Read more
Purespring Therapeutics
Purespring Therapeutics is charging ahead with a groundbreaking $105 million funding boost to redefine kidney disease treatment, starting with an innovative trial for IgA Nephropathy that could change the lives of millions! Read more
Nuclera
Nuclera secures $75 million in Series C funding to revolutionize protein production and streamline drug discovery, setting the stage for a biotech breakthrough! Read more
Quantexa
Quantexa secures USD 175 million in Series F funding, hitting a USD 2.6 billion valuation. Get ready for smarter data-driven decisions! Read more
Investments By Sector
British Patient Capital has invested in these sectors
| Biotech | 35.3% |
| Fintech | 35.3% |
| Healthtech | 17.6% |
| AI | 11.8% |
